Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
Seven Core Pieces of the Puzzle: What to Consider When Selecting an Analytical Lab
Bridging the Divide: Understanding Contrasting Approaches in Drug Development
Updates on the Value of a Day of Delay in Drug Development
CEO Spotlight: Matthew Stober
CDMO Specialization
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
FDA Approves Roche's Itovebi for Breast Cancer
Evonik to Restructure Keto and Pharma Amino Acid Business
Hubble Therapeutics Selects Andelyn to Manufacture Clinical Grade AAV
Cellipont Bioservices, Mongoose Bio Partner to Advance MGB-001
Lipocine Enters Exclusive Supply and Distribution Agreement with Pharmalink
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
Evonik to Restructure Keto and Pharma Amino Acid Business
Application of QbD Approach for Tech Transfer and Process Characterization of Biologics
Rommelag CDMO
Hubble Therapeutics Selects Andelyn to Manufacture Clinical Grade AAV
Cellipont Bioservices, Mongoose Bio Partner to Advance MGB-001
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Nipro Launches D2F Glass Vials Using Stevanato's EZ-fill Technology
Thermo Fisher Scientific to Leverage DHL Express GoGreen Plus Service
SK pharmteco, Cryoport Partner for Cell and Gene Therapy Logistics and BioServices
Pharma Matters Q&A: Rising Above the Rest
Avara Highlights Recent Expansions and Core Capabilities
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Application of QbD Approach for Tech Transfer and Process Characterization of Biologics
Hubble Therapeutics Selects Andelyn to Manufacture Clinical Grade AAV
Arbele Enters AI Alliances in Precision Oncology and Manufacturing
Panthera Biopartners Joins Parexel Site Alliance Vaccine Network
Lilly, insitro Enter Strategic Agreements for Metabolic Diseases
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Rottendorf Pharma Selects ValGenesis VLMS
FDA sIRB Mandate: A Chance to Reassess Site Performance
Rottendorf Pharma Selects ValGenesis’ VLMS
U.S. House of Representatives Passes the BIOSECURE Act
Post-COVID Trends in Biopharma Contract Manufacturing
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
TaiMed Biologics
BioTechnique
Abzena
Syngene International Ltd.
LOTTE BIOLOGICS
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
TaiMed Biologics
BioTechnique
Abzena
Syngene International Ltd.
LOTTE BIOLOGICS
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 20 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Cytotoxics and High Potency Manufacturing
All
APIs
Aseptic Processing
cGMP Manufacture
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/Technology Transfer
Solid Dosage/Creams/Ointments
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
HPAPIs Soar Riding the Targeted Drugs Wave
Potent therapies—the new mantra.
Soman Harachand, Contributing Writer, Contract Pharma
09.05.24
Aseptic Processing
|
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
|
Fill/Finish
|
Industry News
Agilent to Acquire North American CDMO BioVectra
Expands Agilent’s biopharma services for drug discovery, development, and manufacturing.
07.24.24
Capsules
|
Cytotoxics and High Potency Manufacturing
|
Solid Dosage/Creams/Ointments
|
Solid Dosage/Semi-solids
Good as Gold: Douglas CDMO
The New Zealand-based CDMO making a global impact.
Sponsored
released by
Douglas CDMO
07.15.24
APIs
|
Breaking News
|
Cytotoxics and High Potency Manufacturing
|
Facilities
|
Fill/Finish
|
Industry News
Olon Group Acquires GTP Bioways
Expands capabilities for the development and production of ADCs.
07.03.24
APIs
|
Breaking News
|
Cytotoxics and High Potency Manufacturing
|
Facilities
|
Industry News
Siegfried to Acquire Early-Phase CDMO in Wisconsin
Deal to strengthen its drug substances service offering in terms of capabilities and geography.
06.18.24
Breaking News
|
Cytotoxics and High Potency Manufacturing
|
Promotions & Moves
Actylis Names Scott Thomson as CEO
Thomson offers a three-decade track record in the pharmaceutical and chemical industries.
06.17.24
Capsules
|
Cytotoxics and High Potency Manufacturing
|
Solid Dosage/Creams/Ointments
|
Solid Dosage/Semi-solids
Multi-particulate Formulations – Tablets or Capsules?
Multiple-unit dosage forms are gaining significant popularity among drug developers due to their benefits.
Subhashis Chakraborty and Ananya Sen, ACG
03.11.24
Cytotoxics and High Potency Manufacturing
|
Drug Development
Trends in the Development of ADCs
Targeting tumor heterogeneity with antibody-drug conjugates and novel payloads.
Louise Duffy, Chief Technical Officer, Abzena
02.01.24
Cytotoxics and High Potency Manufacturing
|
Drug Development
|
Process Development
HPAPI Trends: Drug Synthesis in Early Development
Addressing the challenge of new clinical targets and highly potent compounds.
Rob Abbenhuis, Chemistry Division Manager, Ardena
02.01.24
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
|
Drug Development
|
Fill/Finish
|
Information Technology
Calling All Laureates in Oncology Drug Manufacturing
Leveraging technology to reduce development timelines while maintaining safety will be key to delivering critical oncology products.
Rebecca Coutts, General Manager, PCI Pharma Services
02.01.24
APIs
|
Breaking News
|
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
Olon Group to Add New High Potency API Suite in Ohio
Expands its capabilities to serve clients developing innovative therapies for cancer, rare diseases and other challenging therapeutic areas.
01.29.24
APIs
|
Cytotoxics and High Potency Manufacturing
Trends in the Development of ADCs
Targeting tumor heterogeneity with antibody-drug conjugates and novel payloads.
Louise Duffy, Chief Technical Officer, Abzena
01.25.24
APIs
|
Cytotoxics and High Potency Manufacturing
API Market Trends
Companies are looking to diversify their API suppliers and manufacturers to different locations instead of outsourcing it to just one manufacturer.
Online Exclusives
Grand View Research
01.25.24
Breaking News
|
Cytotoxics and High Potency Manufacturing
|
Drug Development
|
Drug Discovery
|
Industry News
Experic Installs New Capsule Filling Machine at New Jersey Facility
Provides enhanced protection of employees and the environment from highly potent pharmaceutical products.
12.07.23
Cytotoxics and High Potency Manufacturing
Developing HPAPIs: Leveraging Classification Systems to Mitigate Risk
Exploring the importance of robust classification systems to accurately characterize and classify HPAPIs for safe handling.
Catherine Wilkes, Executive Director of Environmental, Health & Safety, Quotient Sciences
11.14.23
Cytotoxics and High Potency Manufacturing
ABCs of ADCs: A Brief Primer
Reviewing some pros and cons that exist within the outsourcing realm for antibody drug conjugates.
Ben Locwin , Contributing Editor
11.14.23
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
The Evolution of HPAPI Manufacturing for CDMOs
The demand for highly potent APIs has been steadily increasing, driven by the development of targeted therapies in oncology and other disease areas.
Adam Kujath, EVP and Site Head, Germantown, Sterling Pharma Solutions
10.12.23
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
"3 Key Trends" with Srinivasan Shanmugam
Adare Pharma Solutions’ Senior Director of Pharmaceutical Sciences, Business Support, and New Technologies offers his thought leadership.
Online Exclusives
Contract Pharma
09.28.23
Cytotoxics and High Potency Manufacturing
|
Facilities
HPAPI Manufacturing Trends
Oncology drugs, advancements in manufacturing technology, and a rise in capacity to meet greater demand drive market growth.
Tim Wright, Editor, Contract Pharma
09.13.23
Cytotoxics and High Potency Manufacturing
|
Drug Development
"3 Key Trends" with Louise Duffy
Abzena’s Chief Technical Officer offers her thought leadership.
Online Exclusives
Contract Pharma
08.04.23
Breaking News
FDA Approves Roche's Itovebi for Breast Cancer
Evonik to Restructure Keto and Pharma Amino Acid Business
Hubble Therapeutics Selects Andelyn to Manufacture Clinical Grade AAV
Cellipont Bioservices, Mongoose Bio Partner to Advance MGB-001
Lipocine Enters Exclusive Supply and Distribution Agreement with Pharmalink
View Breaking News >
CURRENT ISSUE
September 2024
Seven Core Pieces of the Puzzle: What to Consider When Selecting an Analytical Lab
Bridging the Divide: Understanding Contrasting Approaches in Drug Development
Updates on the Value of a Day of Delay in Drug Development
CEO Spotlight: Matthew Stober
CDMO Specialization
Post-COVID Trends in Biopharma Contract Manufacturing
Pharma’s Next Frontier: GLP-1s and Other New Therapies
CEO Spotlight: Prasad Raje
HPAPIs Soar Riding the Targeted Drugs Wave
View More >